Suppr超能文献

探讨甲氨蝶呤在双相情感障碍躁狂发作中的诱发作用:病例报告。

Contribution of methotrexate in precipitation of manic episode in bipolar affective disorder explored: a case report.

机构信息

Institute of Mental Health, Singapore.

出版信息

Ther Adv Psychopharmacol. 2013 Aug;3(4):251-4. doi: 10.1177/2045125313477103.

Abstract

Bipolar affective disorder is characterized by recurring episodes of mania with or without, but commonly with, episodes of depression. It usually begins in adolescence and can cause enduring and substantial impairment if left untreated. It needs a long-term treatment with mood stabilizers to prevent relapses. Elevated or depressed mood relapses can be either primary or secondary. However, primary mood relapses can occur without a significant precipitating factor, more often tending to occur following stressful life events or discontinuation of mood stabilizer medications. Secondary mood relapses can be caused by many conditions, such as physical illnesses, substance misuse and medications. When a mental illness coexists with another physical illness and the treatment of one complicates the other, it adds complexity to the selection of appropriate pharmacological regime for either condition. In this paper, the authors present a case of bipolar affective disorder who had two episodes of mania likely precipitated by methotrexate, which were reversed by the withdrawal of the offending drug (methotrexate). To the best of the authors' knowledge, to date there have been no published reports in the literature in which methotrexate, an immunosuppressive and a cytotoxic drug, precipitated a manic episode in a patient with bipolar affective disorder.

摘要

双相情感障碍的特征是反复发作的躁狂症,伴有或不伴有,通常伴有,抑郁症发作。如果不治疗,它通常会在青春期开始,并可能导致持久和实质性的损害。它需要长期的情绪稳定剂治疗,以防止复发。情绪升高或降低的复发可能是原发性的或继发性的。然而,原发性情绪复发可能没有明显的诱发因素,更常见于应激性生活事件或情绪稳定剂药物停药后发生。继发性情绪复发可能由多种情况引起,如身体疾病、物质滥用和药物。当一种精神疾病与另一种身体疾病共存,而一种疾病的治疗使另一种疾病复杂化时,这就增加了为任何一种疾病选择适当的药物治疗方案的复杂性。在本文中,作者介绍了一例双相情感障碍患者,该患者有两次躁狂发作,可能由甲氨蝶呤诱发,停用该药物后躁狂症得到逆转。据作者所知,迄今为止,文献中尚无报道称甲氨蝶呤,一种免疫抑制剂和细胞毒性药物,会诱发双相情感障碍患者的躁狂发作。

相似文献

2
[Antipsychotics in bipolar disorders].[双相情感障碍中的抗精神病药物]
Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5.
5
Acute and maintenance treatment with mood stabilizers.使用心境稳定剂进行急性和维持治疗。
Int J Neuropsychopharmacol. 2003 Sep;6(3):269-75. doi: 10.1017/S1461145703003535.
7
ECNP consensus meeting. Bipolar depression. Nice, March 2007.欧洲神经精神药理学会共识会议。双相抑郁症。英国尼斯,2007年3月。
Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23.
10
Olanzapine in long-term treatment for bipolar disorder.奥氮平用于双相情感障碍的长期治疗。
Cochrane Database Syst Rev. 2009 Jan 21(1):CD004367. doi: 10.1002/14651858.CD004367.pub2.

本文引用的文献

2
Acute mania in the setting of severe hypothyroidism.严重甲状腺功能减退情况下的急性躁狂。
Psychosomatics. 2005 May-Jun;46(3):259-61. doi: 10.1176/appi.psy.46.3.259.
8
Reduced red-cell folate in mania.躁狂症患者红细胞叶酸水平降低。
J Affect Disord. 1997 Nov;46(2):95-9. doi: 10.1016/s0165-0327(97)00096-7.
9
Nerve lesions after therapy for childhood acute lymphoblastic leukemia.
Cancer. 1998 Jan 1;82(1):200-7. doi: 10.1002/(sici)1097-0142(19980101)82:1<200::aid-cncr25>3.0.co;2-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验